regeneron
Entity, reached from Hormuz.
- Evidence
- 48 documents · 25 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 8 Apr 2026, last seen 7 Oct 2026
- Measured
- 17% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- SEC · 2026-10-06 · 8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer) (opens the source in a new tab)
- AllSci News · 2026-10-04 · Regeneron’s ubamatamab posts 73% response rate in small LGSOC cohort (opens the source in a new tab)
- Medical Daily · 2026-10-04 · Experimental Regeneron Antibody Trevogrumab Cut Lean Mass Loss by About 42% in Semaglutide Users Over One Year (opens the source in a new tab)
- Endpoints News · 2026-10-03 · Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more (opens the source in a new tab)
- BioPharma Dive · 2026-10-02 · Sanofi, Regeneron broaden alliance to find their next Dupixent (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-02 · EASD 2026: Regeneron’s muscle preserver shows benefit at lower doses (opens the source in a new tab)
- Endpoints News · 2026-10-02 · #EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy (opens the source in a new tab)
- Endpoints News · 2026-10-02 · #EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapy (opens the source in a new tab)
- Endpoints News · 2026-10-01 · Sanofi builds on immunology alliance with Regeneron for $1B upfront (opens the source in a new tab)
- STAT News · 2026-10-01 · STAT+: Sanofi, Regeneron expand partnership after Dupixent success (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with sanofi (21 documents)seen together
- co-mentioned with fda (16 documents)seen together
- co-mentioned with pfizer (13 documents)seen together
- co-mentioned with studie (12 documents)seen together
- co-mentioned with amgen (11 documents)seen together
- co-mentioned with eli lilly (11 documents)seen together
- co-mentioned with roche (11 documents)seen together
- co-mentioned with abbvie (10 documents)seen together
- co-mentioned with bristol myers squibb (10 documents)seen together
- co-mentioned with novartis (9 documents)seen together